Search Orphan Drug Designations and Approvals
-
Generic Name: | N-[5-(6-fluoro-8-{[4-(2-hydroxypropan-2-yl)piperidin-1-yl]methyl}-2-morpholinoquinazolin-4-yl)-2-methoxypyridin-3-yl]methanesulfonamide |
---|---|
Date Designated: | 10/10/2018 |
Orphan Designation: | Treatment Follicular Lymphoma |
Orphan Designation Status: | Designated |
FDA Orphan Approval Status: | Not FDA Approved for Orphan Indication |
Sponsor: |
Shanghai Yingli Pharmaceutical Co., Ltd. No.1 Building, 998 Halei Road Zhangiiang Hi-tech Park, Pudong New Area Shanghai, Shanghai China The sponsor address listed is the last reported by the sponsor to OOPD. |
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-